🔍
Search Results - david+volsky
1
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Glutamine Antagonists for the Treatment of Cognitive Deficits, including NeuroAIDs
Some glutamine antagonists have been shown to have anti-cancer activities in multiple preclinical and clinical studies. However the toxicity of the glutamine antagonists at doses necessary for their anticancer effects have hampered their clinical development. Herein we describe a completely novel use for the glutamine antagonists. Using a prototype...
Published: 3/13/2025
|
Inventor(s):
Barbara Slusher
,
David Volsky
,
Kristen Hollinger
,
Michael Nedelcovych
,
Atsushi Kamiya
Keywords(s):
Antagonists/Inhibitors
,
CNS and Neurological Disorders
,
Cognitive Impairment
,
Disease Indication
,
HIV/AIDS
,
HIV-Associated Neurocognitive Disorders
,
Non-novel
,
Predicted Novelty
,
Repurposed
,
Small Molecules
,
Therapeutic Matter
,
Therapeutic Substance
,
Therapeutics
Category(s):
Clinical and Disease Specializations
,
Clinical and Disease Specializations > Infectious Diseases > HIV/AIDS
,
Clinical and Disease Specializations > Neurology > Cognitive Impairment
,
Clinical and Disease Specializations > Neurology > HIV-Associated Neurocognitive Disorders
,
Technology Classifications > Therapeutic Modalities > Small Molecules
,
Clinical and Disease Specializations > Infectious Diseases
,
Clinical and Disease Specializations > Neurology
,
Technology Classifications > Therapeutic Modalities
JHTV Home
|
Search
|
Login/Subscribe
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by
Inteum